Asi Haviv
Hoofd Techniek/Wetenschap/O&O bij MEDIWOUND LTD.
Oorsprong van het eerstegraads netwerk van Asi Haviv
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 28 | |
| Public Company | Pharmaceuticals: Major | 19 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Asi Haviv via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| The Hebrew University of Jerusalem | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
| CACTUS ACQUISITION CORP. 1 LIMITED | Financial Conglomerates | Director of Finance/CFO Chairman Chief Executive Officer | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Executive Officer Corporate Secretary Director/Board Member | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Director/Board Member General Counsel Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Consultant / Advisor | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | General Counsel Director/Board Member | |
Israel Bar Association
 Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| KAMADA LTD. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| ACUSPHERE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| EXALENZ BIOSCIENCE LTD | Medical Specialties | Director/Board Member Director/Board Member | |
| STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Corporate Officer/Principal Doctorate Degree | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| University of Haifa | College/University | Graduate Degree Undergraduate Degree | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| George Washington University | College/University | Undergraduate Degree Masters Business Admin | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of New Hampshire | College/University | Undergraduate Degree Undergraduate Degree | |
| DERMA SCIENCES INC | Medical Specialties | Chief Executive Officer Public Communications Contact | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Medical Specialties | President Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member | |
| Campus Bio LLP | Director/Board Member | ||
| CLAL Application Center Ltd. | Chairman | ||
| Center Ltd. | Director/Board Member | ||
Biomedical Investments
 Biomedical Investments Investment ManagersFinance Biomedical Investments operates as a private investment company. It focuses its investments on start-ups with breakthrough technologies, applicable in emerging therapeutic segments. The company was founded in 1997 and is headquartered in Tel-Aviv, Israel. | Investment Managers | Chief Executive Officer | |
ARTE Venture Group Ltd.
 ARTE Venture Group Ltd. Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., ARTE Venture Group Ltd. is an alternative investment manager. The company is based in Ramat Gan, Israel. ARTE Venture Group was founded in 2003. | Investment Managers | Corporate Officer/Principal | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Bank of Israel | General Government | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 29 |
| Israël | 19 |
| Verenigd Koninkrijk | 3 |
| Ierland | 2 |
| Turkije | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 10 |
| Finance | 6 |
| Miscellaneous | 2 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 195 |
| Corporate Officer/Principal | 94 |
| Chief Executive Officer | 51 |
| Independent Dir/Board Member | 47 |
| Undergraduate Degree | 36 |
Sterkste connecties
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Ofer Gonen | 31 |
| David Stack | 27 |
| James Tobin | 26 |
| Stephen Wills | 22 |
| Mark Leuchtenberger | 21 |
| Gary Patou | 17 |
| Vincent J. Miles | 17 |
| Samuel Rubinstein | 17 |
| Fredric D. Price | 16 |
| Homi Shamir | 16 |
| William Ludlam | 13 |
| Vickie R. Driver | 13 |
| John Scarlett | 13 |
| Mark J. Fitzpatrick | 12 |
